Steven J. Rice - Aug 23, 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Chief Administrative Officer
Signature
/s/ Howard Horn, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
Aug 23, 2021
Transactions value $
-$372,400
Form type
4
Date filed
8/24/2021, 06:44 PM
Previous filing
Jun 29, 2021
Next filing
Dec 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Options Exercise $128K +10K +50% $12.76 30K Aug 23, 2021 Direct
transaction VIR Common Stock Sale -$500K -10K -33.33% $50.00 20K Aug 23, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Employee Stock Option (Right to Buy) Options Exercise $0 -10K -2.25% $0.00 434K Aug 23, 2021 Common Stock 10K $12.76 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021.
F2 1/4 of the shares subject to the stock option vest and become exercisable on September 15, 2020, and the remainder vest in 36 equal monthly installments thereafter.